Effort could speed diagnostics, treatments for poorly understood conditions Millions of people worldwide are estimated to suffer from lymphatic diseases but diagnosing and treating them is difficult, in part because a full understanding of the lymphatic system is lacking, researchers say. While there’s no cure for lymphatic diseases, the current...
NIH-funded observational study shows risk grows sharply with more frequent use Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke, according to an observational study supported by the National Institutes of Health. The study, published in the Journal of the American Heart Association , uses data from...
Statement from Gary H. Gibbons, M.D., Director of NHLBI: I take great pleasure in announcing that Rear Admiral Richard Childs, M.D. , has accepted the position of Scientific Director (SD) of the Division of Intramural Research (DIR), effective February 7, 2024. Childs has served as NHLBI Clinical Director since 2013 and Acting Scientific Director...
NIH-funded tool can accurately identify the potentially life-threatening inflammatory disease A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs in...
The purpose of this meeting is to update the Advisory Board and public stakeholders on the progress of sleep and circadian research activities across NIH, and the activities of Federal stakeholders and interested organizations. The meeting will be held as a hybrid (in-person/virtual) meeting and will be open to the public; however, registration is required. The meeting can be attended in person at National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Rm 260C/D, Bethesda, MD 20817 or accessed virtually from the NIH Videocast.
Hybrid (Virtual/In-Person) Meeting In Person: Rockledge II, Room 260 C/D
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) is participating in AHA 2023, the American Heart Association’s 2023 Scientific Sessions. This is the premier global event for advancements in cardiovascular science and medicine.
Pennsylvania Convention Center
1101 Arch St.
Philadelphia, PA 19107
NHLBI will be sharing information and upcoming plans for the refresh and how you can provide input. During each webinar, NHLBI division and center directors will review research progress. They will also discuss focus areas for the refresh, answer questions, and gather inputs and ideas.
Virtual Webinar Series
11 a.m.-12 p.m. ET
See full schedule below